Clinical Study
Prognostic Significance of Immunohistochemical Phenotypes in Patients Treated for High-Grade Cervical Intraepithelial Neoplasia
Table 2
Positivity of immunohistochemical targets within the stroma.
| | NED | REC | | | | <5% | >5% | <5% | >5% | Fisher exact | Phi |
| CD4+ | 3 (13.6%) | 19 (86.4%) | 12 (100%) | 0 (0%) | <0.0001 | −0.83 | CD8+ | 13 (59.1%) | 9 (40.9%) | 10 (83.3%) | 2 (16.7%) | n.s. | −0.25 | T-bet+ | 3 (13.6%) | 19 (86.4%) | 12 (100%) | 0 (0%) | <0.0001 | −0.83 | GATA3+ | 14 (63.6%) | 8 (36.4%) | 7 (83.3%) | 5 (41.7%) | n.s. | 0.05 | CD11c+ | 4 (18.2%) | 18 (81.8%) | 10 (83.3%) | 2 (16.7%) | 0.0001 | −0.63 |
|
|
NED: not evidence of disease; REC: recurrence of disease.
|